Quality control of fifteen probiotic products containing Saccharomyces boulardii

Journal of Applied Microbiology
L M E VanheeT Coenye

Abstract

The yeast Saccharomyces boulardii is used as a probiotic for the prevention and treatment of diarrhoea. In this study, the quality of 15 probiotic products containing S. boulardii was verified. Using microsatellite typing, the identity of all Saccharomyces strains in the products was confirmed as S. boulardii. Additionally, solid-phase cytometry (SPC) and a plate method were used to enumerate S. boulardii cells. SPC was not only able to produce results more rapidly than plating (4h compared to 48h) but the cell counts obtained with SPC were significantly higher than the plate counts. Finally, we found that <1% of the S. boulardii cells survived 120min in gastric conditions and storage for 3months at 40°C with 75% relative humidity. We developed a SPC method for the quantification of viable S. boulardii cells in probiotics. Additionally, we demonstrated that gastric conditions and storage have a marked effect on the viability of the yeast cells. To our knowledge, this is the first time SPC is used for the quality control of probiotics with S. boulardii. Additionally, we demonstrated the need for gastric protection and accurate storage.

References

Nov 1, 1990·The Journal of Antimicrobial Chemotherapy·O Kourilsky
Jul 1, 1989·Biopharmaceutics & Drug Disposition·H BlehautR H Levy
Apr 1, 1997·Cytometry·K Mignon-GodefroyC Butor
Aug 15, 1998·Journal of Clinical Microbiology·M J McCulloughD A Stevens
Dec 14, 1999·Alimentary Pharmacology & Therapeutics·G W ElmerR N Greenberg
Feb 7, 2001·Journal of Clinical Microbiology·C HennequinB Dujon
Oct 7, 2004·Canadian Journal of Microbiology·Juliana L R FiettoIeso M Castro
Mar 8, 2005·Journal of Clinical Microbiology·J Y MalgoireM Mallié
Aug 16, 2005·International Journal of Food Microbiology·Brunella PosteraroGiovanni Fadda
May 19, 2006·Journal of Pediatric Gastroenterology and Nutrition·Hania SzajewskaStefano Guandalini
Jul 14, 2006·Digestive Diseases and Sciences·Jean-Paul Buts, Nadine De Keyser
Feb 13, 2007·Applied and Environmental Microbiology·Laura Edwards-IngramLubomira Stateva
Feb 2, 2008·Biological & Pharmaceutical Bulletin·Sandrine GraffChristine Charrueau
Sep 20, 2008·The Journal of General and Applied Microbiology·Sandrine GraffChristine Charrueau
Aug 27, 2009·Alimentary Pharmacology & Therapeutics·C Pothoulakis

❮ Previous
Next ❯

Citations

May 4, 2013·Current Infectious Disease Reports·Y VandenplasB Hauser
Oct 30, 2012·Gastroenterology Clinics of North America·Fergus Shanahan
Apr 7, 2016·Best Practice & Research. Clinical Gastroenterology·Yvan Vandenplas
Sep 15, 2011·Journal of Applied Microbiology·K Honraet, L Delcour
Sep 15, 2011·Journal of Applied Microbiology·T Coenye, H J Nelis
Feb 26, 2019·Letters in Applied Microbiology·J F Garcia-MazcorroJ R Kawas
Oct 5, 2019·The Journal of Eukaryotic Microbiology·Katarzyna B Hooks, Maureen A O'Malley
Apr 6, 2021·Critical Reviews in Food Science and Nutrition·Vincenzina FuscoDaniele Chieffi
Aug 7, 2021·Frontiers in Microbiology·Diletta MazzantiniEmilia Ghelardi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.